CJC1295/Ipamorelin (no DAC) 5/5mg

$55.00

#Purchased

Discount

5-9

5%

10 or more

10%

Quantity *

Out of stock

Research Application

CJC-1295 without DAC (also known as Modified GRF 1-29 or Mod GRF (1-29)) is a synthetic oligopeptide analogue of growth hormone-releasing hormone (GHRH), consisting of 29 amino acids with tetrasubstituted modifications at positions 2 (D-Ala), 8 (Gln), 15 (Ala), and 27 (Leu) to confer resistance to enzymatic degradation and improved receptor affinity compared to native GHRH(1-29), without the Drug Affinity Complex (DAC) extension for albumin binding. Ipamorelin (also known as NNC-26-0161) is a synthetic pentapeptide (5 amino acids long) designed as a selective ghrelin mimetic and growth hormone secretagogue receptor (GHSR) ligand, featuring non-natural amino acids including α-aminoisobutyric acid (Aib) at the N-terminus, D-2-naphthylalanine (D-2-Nal), and D-phenylalanine for enhanced stability and receptor specificity, with C-terminal amidation.

Storage

Store in a cool, dark place or freeze at -20°C for long term storage. Refrigerate after reconstitution

Molecular Description 

CJC1295 (no DAC): 5MG

 

Ipamorelin: 5MG

CJC-1295 without DAC (also known as Modified GRF 1-29 or Mod GRF (1-29)) is a synthetic oligopeptide analogue of growth hormone-releasing hormone (GHRH), consisting of 29 amino acids with tetrasubstituted modifications at positions 2 (D-Ala), 8 (Gln), 15 (Ala), and 27 (Leu) to confer resistance to enzymatic degradation and improved receptor affinity compared to native GHRH(1-29), without the Drug Affinity Complex (DAC) extension for albumin binding.

Its amino acid sequence is: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (C-terminal amidation).

 

Ipamorelin (also known as NNC-26-0161) is a synthetic pentapeptide (5 amino acids long) designed as a selective ghrelin mimetic and growth hormone secretagogue receptor (GHSR) ligand, featuring non-natural amino acids including α-aminoisobutyric acid (Aib) at the N-terminus, D-2-naphthylalanine (D-2-Nal), and D-phenylalanine for enhanced stability and receptor specificity, with C-terminal amidation.

Its amino acid sequence is: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (or H-Aib-His-D-2Nal-D-Phe-Lys-NH₂).

Chemically, it has the molecular formula C₃₈H₄₉N₉O₅ and a molar mass of approximately 711.85–711.87 g/mol (CAS 170851-70-4). This oligopeptide is classified as a research chemical and is commonly utilized in laboratory investigations of GHSR-mediated pathways, peptide-receptor interactions, and related biochemical processes

 

LEGAL DISCLAIMER!

 

All items available on this website are intended exclusively for research and development purposes, including laboratory and analytical applications, and are not meant for human or animal consumption in any form. The products are not designed to diagnose, treat, cure, or prevent any medical conditions, and their associated claims have not been reviewed or approved by the U.S. Food and Drug Administration. Purus Peptides operates solely as a supplier of research chemicals and is neither a compounding pharmacy nor an outsourcing facility as defined by sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

we apologize for the inconvenience

Our Credit Card Processor isn’t working right now.  We can still accept Zelle, Venmo and Link Money (bank transfer)

30% off your first order

Important Disclaimer

Most products are sold in powder (lyophilized) form and require reconstitution with a suitable dilutant for research purposes only. Research supplies (e.g., syringes, bacteriostatic water) are not included. No dosing instructions are provided. We adhere to all local and state laws around Research Only Chemical sales. We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption. Please review our terms and conditions carefully before making a purchase on our website.

You must be 21 years of age or older

By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above.